Syntaxin and 25-kDa synaptosomal-associated protein: Differential effects of botulinum neurotoxins C1 and a on neuronal survival

Journal of Neuroscience Research

Volumn 52, Issue 5, 1998, Pages 569-583

  Williamson, Lura C ^a   Neale, Elaine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Clostridial; Fusion proteins; SNARES; Synaptic

Indexed keywords

BOTULINUM TOXIN; CELL PROTEIN; HYBRID PROTEIN; SYNTAXIN;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; FETUS; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NERVE FIBER GROWTH; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD NERVE CELL; SYNAPSE; SYNAPTOGENESIS;

EID: 0032101149     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980601)52:5<569::AID-JNR9>3.0.CO;2-A     Document Type: Article

References (45)

1. Alderson K, Holds JB, Andersen RL (1991): Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41: 1800-1805.
2. Bergey GK, Bigalke H, Nelson PG (1987): Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: A presynaptic locus of action for tetanus toxin. J Neurophysiol 57:121-131.
3. Bezprozvanny I, Scheller RH, Tsien RW (1995): Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378:623-626.
4. Bigalke H, Dreyer F, Bergey G (1985): Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res 360:318-324.
5. Binz T, Blasi J, Yamasaki S, Baumeister A, Link E, Südhof TC, Jahn R, Niemann H (1994): Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269:1617-1620.
6. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Südhof TC, Niemann H, Jahn R (1993a): Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163.
7. Blasi J, Chapman ER, Yamasaki S. Binz T, Niemann H, Jahn R (1993b): Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBOJ 12:4821-4828.
8. Brenneman DE, Neale EA. Habig WH, Bowers LM, Nelson PG (1983): Developmental and neurochemical specificity of neuronal deficits produced by electrical impulse blockade in dissociated spinal cord cultures. Dev Brain Res 9:13-27.
9. Brin M (ed) (1997): Spasticity: Etiology, evaluation, management and the role of botulinum toxin type A. Muscle Nerve 20(Suppl 6) S1-S231.
10. Caceres A, Banker G, Steward O. Binder L, Payne M (1984): MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Dev Brain Res 13:314-318.
11. Duchen LW (1970): Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: Differences between fast and slow muscles. J Neurol Neurosurg Psychiatr 33:40-54.
12. Fitzgerald SC (1989): Dissociated spinal cord-dorsal root ganglion cultures on plastic tissue culture dishes and glass coverslips and wells. In Shahar A, deVellis J, Vernadakis A, Haber B (eds): "A Dissection and Tissue Culture Manual of the Nervous System." New York: Alan R. Liss, Inc., pp 219-222.
13. Foran P, Lawrence GW, Shone CC, Foster KA, Dolly JO (1996): Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release. Biochemistry 35:2630-2636.
14. George EB, Glass JD, Griffin JW (1995): Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 15:6445-6452.
15. Giloh H, Sedat JW (1982): Fluorescence microscopy: Reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate. Science 217:1252-1255.
16. Habig WH, Bigalke H, Bergey GK, Neale EA, Hardegree MC, Nelson PG (1986): Tetanus toxin in dissociated spinal cord cultures: Long-term characterization of form and action. J Neurochem 47:930-937.
17. Igarashi M, Kozaki S, Terakawa S, Kawano S, Ide C, Komiya Y (1996): Growth cone collapse and inhibition of neurite growth by botulinum neurotoxin C1: A t-SNARE is involved in axonal growth. J Cell Biol 134:205-215.
18. Jankovic J, Hallet M (eds) (1994): "Therapy with Botulinum Toxin." New York: Marcel Dekker, Inc.
19. Kamata Y, Nishiki T, Matsumura K, Hiroi T, Kozaki S (1994): Morphological effects, rate of incorporation, and the enzymatic action of botulinum ADP-ribosyltransferase, known as C3 exoenzyme, on human neuroblastoma GOTO cells. Microbiol Immunol 38:421-428.
20. Marsden CD, Koller W (eds) (1997): Botulinum toxin in the future. In Proceedings of the Third European Botulinum Toxin Symposium, February 28-March 2, 1997, London, UK: Rapid Science Publishers, 91 pp. Eur J Neurol 4(Suppl 2), pp S1-S91.
21. Neale EA, Macdonald RL, Nelson PG (1978): Intracellular horseradish peroxidase injection for correlation of light and electron microscopic anatomy with synaptic physiology of cultured mouse spinal cord neurons. Brain Res 152:265-282.
22. Neale EA, Bowers LM, Smith TG Jr (1993): Early dendrite development in spinal cord cell cultures: A quantitative study. J Neurosci Res 34:54-66.
23. 2+ channel complex. FEBS Lett 326: 255-260.
24. Osen-Sand A, Catsicas M, Staple JK, Jones KA, Ayala G, Knowles J, Grenningloh G, Catsicas S (1993): Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364:445-448.
25. Osen-Sand A, Staple JK, Naldi E, Schiavo G, Rossetto O, Petitpierre S, Malgaroli A, Montecucco C, Catsicas S (1996): Common and distinct fusion proteins in axonal growth and transmitter release. J Comp Neurol 367:222-234.
26. Ransom BR. Neale E, Henkart M, Bullock PN, Nelson PG (1977): Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties. J Neurophysiol 40:1132-1150.
27. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C (1992a): Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832-835.
28. Schiavo G, Rossetto O, Santucci A, DasGupta BR, Montecucco C (1992b): Botulinum neurotoxins are zinc proteins. J Biol Chem 267:23479-23483.
29. Schiavo G, Rossetto O. Catsicas S, Polverino de Laureto P, DasGupta B, Benfenati F, Montecucco C (1993a): Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268:23784-23787.
30. Schiavo G, Santucci A, DasGupta BR, Metha PP, Jontes J, Benfenati F, Wilson MC, Montecucco C (1993b): Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335:99-103.
31. Schiavo G, Shone CC, Bennett MK, Scheller RH, Montecucco C (1995): Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of different syntaxins. J Biol Chem 270:10566-10570.
32. Schulze KL, Broadie K. Perin MS, Bellen HJ (1995): Genetic and electrophysiological studies of Drosophila syntaxin-1A demonstrate its role in nonneuronal secretion and neurotransmission. Cell 80:311-320.
33. Sheng Z-H, Rettig J. Takahashi M, Catterall WA (1994): Identification of a syntaxin-binding site on N-type calcium channels. Neuron 13:1303-1313.
34. Sheng Z-H, Rettig J, Cook T, Catterall WA (1996): Calcium dependent interaction of N-type calcium channels with the synaptic rore complex. Nature 379:451-454.
35. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE (1993a): SNAP receptors implicated in vesicle targeting and fusion. Nature 362:318-324.
36. Söllner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE (1993b): A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 75:409-418.
37. Stanley EF, Mirotznik RR (1997): Cleavage of syntaxin prevents G-protein regulation of presynaptic calcium channels. Nature 385:340-343.
38. Sternberger LA, Sternberger NH (1983): Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80:6126-6130.
39. Tigyi G, Fischer DJ, Sebok A, Marshall F, Dyer DL, Miledi R (1996): Lysophosphatidic acid-induced neurite retraction in PC12 cells: Neurite-protective effects of cyclic AMP signaling. J Neuro-chem 66:549-558.
40. Tucker LM, Motion AJ (1995): A simple method for quantifying changes in neuronal populations in primary cultures of dissociated rat brain. J Neurosci Methods 59:217-223.
41. Williamson LC, Fitzgerald SC, Neale EA (1992): Differential effects of tetanus toxin on inhibitory and excitatory neurotransmitter release from mammalian spinal cord cells in culture. J Neurochem 59:2148-2157.
42. Williamson LC, Fitzgerald SC, Neale EA (1993): Differential recovery of excitatory and inhibitory neurotransmitter release following tetanus toxin-induced synaptic blockade. Soc Neurosci Abstr 19:1887.
43. Williamson LC, Halpern J, Dunlap V, Neale EA (1995): Botulinum neurotoxin C acts on syntaxin and SNAP-25 and is cytotoxic to neurons. Mol Biol Cell 6:61 a.
44. Williamson LC, Halpern JL, Montecucco C, Brown JE, Neale EA (1996): Clostridial neurotoxins and substrate proteolysis in intact neurons. Botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J Biol Chem 271:7694-7699.
45. 2+channels. EMBO J 15:4100-4110.